Razane El Hajj Chehade, Rashad Nawfal, Karl Semaan, Marc Eid, Eddy Saad, Marc Machaalani, Emre Yekedüz, Clara Steiner, Wassim Daoud Khatoun, David Maj, Martin Zarba, Connor Wells, Sumanta Kumar Pal, Cristina Suarez, Kosuke Takemura, Haoran Li, Sylvan C Baca, Wanling Xie, Daniel Yick Chin Heng, Toni K. Choueiri. "Refining intermediate-risk (IR) stratification in patients (Pts) with metastatic renal cell carcinoma (mRCC) receiving first-line (1L) immunotherapy (IO) within one year of diagnosis (Dx): Findings from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.4556